Heron Therapeutics, Inc. (NASDAQ:HRTX) Director Tang Kevin C purchased 285,714 shares of the company stock in a transaction that occurred on October 4, 2019.
The shares were purchased at an average price of $ 17.50, for a total transaction of $ 5.00 million.
Following the completion of the transaction, the Director now owns 5.80 million shares in the company, valued at approximately 101.50 million.
The transaction was disclosed in a filing with the SEC, which is available through SEC Filing Link.
According to the previous trading day, closing price of HRTX was $ 17.42, representing a 9.99 % increase from the 52 week low of $ 15.68 and a 86.28 % decrease over the 52 week high of $ 32.45.